But will those of us now running on stretched out DNA survive long enough? Especially given government harassment of all things new and government protection of the establishment status quo.
As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits -
HAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a long wait before a much-heralded limb-saving Cuban drug can legally make the 90-mile trip to U.S. shores.
Because of the Cold War-spawned economic blockade against what Washington has long considered the Communist threat in the Caribbean, the developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the U.S. for clinical trials and use.
“I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies …won’t allow that medicine in,” said Dr. I. Kelman Cohen, professor emeritus in surgery at Virginia Commonwealth University.
“I think all the American medical community really wants is for Heberprot to be allowed into the country for testing…Let’s get it tested and see if it will really save the thousands of limbs that many believe it can,” Cohen said.
Diabetes researchers at Umeå University in Sweden reported in 2013 that worldwide, a limb is lost every 20 seconds because of a foot ulcer that doesn’t heal. According to the American Diabetes Association, in the U.S. alone more than 73,000 diabetics undergo amputations every year, or about one every seven minutes.
“It just rips me apart to know that there may be something out there that has the potential to save limbs and we can’t get a chance to test it because of politics rather than public health,” Armstrong said in an interview. Each year, he and his team at the Tucson medical center spend hours in operating rooms trying to save the lower limbs of more than 11,000 patients from around the world. - See more at: http://www.fairwarning.org/2015/01/u-s-bids-renew-relations-havana-heralded-cuban-diabetes-drug-remains-off-limits/#sthash.1cs3kVSC.dpuf
but, but what about the surgeons salaries and the wound management companies billings?we have to protect them, right?
As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits -
HAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a long wait before a much-heralded limb-saving Cuban drug can legally make the 90-mile trip to U.S. shores.
Because of the Cold War-spawned economic blockade against what Washington has long considered the Communist threat in the Caribbean, the developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the U.S. for clinical trials and use.
“I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies …won’t allow that medicine in,” said Dr. I. Kelman Cohen, professor emeritus in surgery at Virginia Commonwealth University.
“I think all the American medical community really wants is for Heberprot to be allowed into the country for testing…Let’s get it tested and see if it will really save the thousands of limbs that many believe it can,” Cohen said.
Diabetes researchers at Umeå University in Sweden reported in 2013 that worldwide, a limb is lost every 20 seconds because of a foot ulcer that doesn’t heal. According to the American Diabetes Association, in the U.S. alone more than 73,000 diabetics undergo amputations every year, or about one every seven minutes.
“It just rips me apart to know that there may be something out there that has the potential to save limbs and we can’t get a chance to test it because of politics rather than public health,” Armstrong said in an interview. Each year, he and his team at the Tucson medical center spend hours in operating rooms trying to save the lower limbs of more than 11,000 patients from around the world. - See more at: http://www.fairwarning.org/2015/01/u-s-bids-renew-relations-havana-heralded-cuban-diabetes-drug-remains-off-limits/#sthash.1cs3kVSC.dpuf
but, but what about the surgeons salaries and the wound management companies billings?we have to protect them, right?
You've got it right..."But will those of us now running on stretched out DNA survive long enough? Especially given government harassment of all things new and government protection of the establishment status quo. "...probably not.
Genervon's 'Master Regulator' Drug Encourages ALS Community Article Highlights: GM604 (also called GM6), in development by Genervon, has been associated with some functional and biochemical benefits in one 12-person trial and one single-person trial in people with ALS. The drug is believed to act as a "master regulator" of genes that are active in the nervous system. There is a community movement to make GM604 available to ALS patients as soon as possible, but the FDA is unlikely to approve the drug until larger, longer studies are conducted.
As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits -
ReplyDeleteHAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a long wait before a much-heralded limb-saving Cuban drug can legally make the 90-mile trip to U.S. shores.
Because of the Cold War-spawned economic blockade against what Washington has long considered the Communist threat in the Caribbean, the developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the U.S. for clinical trials and use.
“I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies …won’t allow that medicine in,” said Dr. I. Kelman Cohen, professor emeritus in surgery at Virginia Commonwealth University.
“I think all the American medical community really wants is for Heberprot to be allowed into the country for testing…Let’s get it tested and see if it will really save the thousands of limbs that many believe it can,” Cohen said.
Diabetes researchers at Umeå University in Sweden reported in 2013 that worldwide, a limb is lost every 20 seconds because of a foot ulcer that doesn’t heal. According to the American Diabetes Association, in the U.S. alone more than 73,000 diabetics undergo amputations every year, or about one every seven minutes.
“It just rips me apart to know that there may be something out there that has the potential to save limbs and we can’t get a chance to test it because of politics rather than public health,” Armstrong said in an interview. Each year, he and his team at the Tucson medical center spend hours in operating rooms trying to save the lower limbs of more than 11,000 patients from around the world.
- See more at: http://www.fairwarning.org/2015/01/u-s-bids-renew-relations-havana-heralded-cuban-diabetes-drug-remains-off-limits/#sthash.1cs3kVSC.dpuf
but, but what about the surgeons salaries and the wound management companies billings?we have to protect them, right?
As U.S. Bids to Renew Relations With Havana, Heralded Cuban Diabetes Drug Remains Off-Limits -
ReplyDeleteHAVANA – President Obama’s efforts to renew relations with Cuba may soon allow Americans to visit this island’s pristine beaches and start lugging home shopping bags filled with long-coveted cigars and rum. But for frustrated American physicians battling to save the feet and legs of tens of thousands of diabetic patients, it may be a long wait before a much-heralded limb-saving Cuban drug can legally make the 90-mile trip to U.S. shores.
Because of the Cold War-spawned economic blockade against what Washington has long considered the Communist threat in the Caribbean, the developer of the medication, the Center for Genetic Engineering and Biotechnology in Havana, is forbidden to bring a nine-year-old drug, called Heberprot-P, to the U.S. for clinical trials and use.
“I don’t know what’s going to happen, but I do know that it may be that American legs are being lost while Cuban legs are being saved because Washington agencies …won’t allow that medicine in,” said Dr. I. Kelman Cohen, professor emeritus in surgery at Virginia Commonwealth University.
“I think all the American medical community really wants is for Heberprot to be allowed into the country for testing…Let’s get it tested and see if it will really save the thousands of limbs that many believe it can,” Cohen said.
Diabetes researchers at Umeå University in Sweden reported in 2013 that worldwide, a limb is lost every 20 seconds because of a foot ulcer that doesn’t heal. According to the American Diabetes Association, in the U.S. alone more than 73,000 diabetics undergo amputations every year, or about one every seven minutes.
“It just rips me apart to know that there may be something out there that has the potential to save limbs and we can’t get a chance to test it because of politics rather than public health,” Armstrong said in an interview. Each year, he and his team at the Tucson medical center spend hours in operating rooms trying to save the lower limbs of more than 11,000 patients from around the world.
- See more at: http://www.fairwarning.org/2015/01/u-s-bids-renew-relations-havana-heralded-cuban-diabetes-drug-remains-off-limits/#sthash.1cs3kVSC.dpuf
but, but what about the surgeons salaries and the wound management companies billings?we have to protect them, right?
You've got it right..."But will those of us now running on stretched out DNA survive long enough? Especially given government harassment of all things new and government protection of the establishment status quo. "...probably not.
ReplyDeleteGenervon's 'Master Regulator' Drug Encourages ALS Community
Article Highlights:
GM604 (also called GM6), in development by Genervon, has been associated with some functional and biochemical benefits in one 12-person trial and one single-person trial in people with ALS.
The drug is believed to act as a "master regulator" of genes that are active in the nervous system.
There is a community movement to make GM604 available to ALS patients as soon as possible, but the FDA is unlikely to approve the drug until larger, longer studies are conducted.
http://alsn.mda.org/news/genervons-master-regulator-drug-encourages-als-community
too bad patients but what else is new??